AntoinetteJosephineWozniakMD

Oncology • Pittsburgh, PA

Hematologic Oncology

Professor of Medicine, University of Pittsburgh

Join to view full profile

Dr. Wozniak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wozniak's full profile

Already have an account?

Office
5115 Centre Avenue
Rm 568
Pittsburgh, PA 15232
Phone+1 412-623-2696

Fax+1 412-648-6579

Education & Training

University of FloridaFellowship, Hematology and Medical Oncology, 1980 - 1983
University at BuffaloResidency, Internal Medicine, 1977 - 1980
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1977

Certifications & Licensure

MI State Medical License 1983 - 2026
PA State Medical License 2018 - 2024
FL State Medical License 1980 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer Start of enrollment: 1995 Oct 01
Completed
Phase 2
S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer Start of enrollment: 2004 Sep 01
Completed
Phase 2
S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer Start of enrollment: 2004 Sep 01
Terminated
Not Applicable
S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery Start of enrollment: 2005 Nov 01
Completed
Phase 2
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer Start of enrollment: 2007 Jul 01
Completed
Phase 2
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer Start of enrollment: 2009 Sep 01
Suspended
Not Applicable
A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib Start of enrollment: 2012 Oct 01
Completed
Phase 1, Phase 2
Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01
Terminated
Not Applicable
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Short Report of a Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM).
Antoinette J Wozniak, Bryan Schneider, Gregory P Kalemkerian, Bobby Daly, Wei Chen
Clinical Lung Cancer. 2023-09-01
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1-Monotherapy Pretreated, Advanced NSCLC: Results From a P...
Edward B Garon, Alexander I Spira, Sarah B Goldberg, Jamie E Chaft, Vassiliki Papadimitrakopoulou
Journal of Thoracic Oncology. 2023-08-01
"I Refused to Get Addicted to Opioids": Exploring Attitudes About Opioid Use Disorder in Patients With Advanced Cancer Pain and Their Support People.
Hailey W Bulls, Megan Hamm, Rachel Wasilko, Flor de Abril Cameron, Shane Belin
The Journal of Pain. 2023-06-01

Lectures

A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM).
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Committees

Member, 2015 Update Committee, American Society of Clinical Oncology (ASCO) 2015 - Present

Professional Memberships

American Society of Clinical Oncology - ASCO
Fellow
Alpha Omega Alpha Honor Medical Society - AOA
Member
American Association for Cancer Research - AACR
Member
American College of Physicians - ACP
Fellow
International Association for the Study of Lung Cancer
Member